GHRH Analog • Growth Hormone Support
Stimulate Natural Growth Hormone Production
CJC-1295 (no DAC) is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary gland to naturally produce more growth hormone. Unlike synthetic HGH, it works with your body’s own rhythms to support recovery, body composition, and vitality. Join our waitlist to be notified when available.
2-10x
GH Level Increase*
1.5-3x
IGF-1 Elevation*
~30
Minute Half-Life
1-3x
Daily Dosing
Growth Hormone Support
A modified GHRH analog that stimulates natural growth hormone release while preserving the body’s pulsatile secretion pattern—the way GH is meant to be released.
5mg per vial
Ideal For
Adults seeking to optimize growth hormone levels naturally for improved recovery, body composition, sleep quality, and overall vitality.
The Science
CJC-1295 (no DAC), also known as Modified GRF (1-29) or Mod GRF, is a synthetic analog of growth hormone-releasing hormone (GHRH). It signals your pituitary gland to produce and release more growth hormone naturally, rather than introducing synthetic HGH from outside the body.
The “no DAC” version has a short half-life of approximately 30 minutes, which preserves the body’s natural pulsatile pattern of GH release. This is important because growth hormone is normally released in pulses, not continuously—and maintaining this rhythm may reduce the risk of receptor desensitization.
Clinical studies showed that GHRH analogs like CJC-1295 can increase GH levels by 2-10 fold and IGF-1 levels by 1.5-3 fold. It’s often combined with a growth hormone secretagogue like Ipamorelin for synergistic effects—the GHRH analog amplifies the signal while the secretagogue triggers the release.
Schedule Consultation
How It Works
CJC-1295 works by mimicking your body’s natural growth hormone-releasing hormone, stimulating the pituitary to produce more GH on its own.
Binds to GHRH receptors on pituitary somatotroph cells, signaling them to synthesize and release growth hormone into circulation.
The short half-life (~30 min) allows GH to be released in natural pulses rather than sustained elevation, preserving physiologic rhythm.
Elevated GH stimulates the liver to produce IGF-1, which mediates many of growth hormone’s anabolic and regenerative effects throughout the body.
Understanding Your Options
The “no DAC” version offers a more physiologic approach to growth hormone optimization compared to the long-acting DAC version.
*Individual responses vary. Consult with our physicians to determine the best approach for your goals.
Potential Benefits
Signals your pituitary to produce its own growth hormone rather than introducing synthetic HGH—working with your body’s natural systems.
Enhanced GH and IGF-1 levels support tissue repair, muscle recovery after exercise, and overall healing processes.
Growth hormone optimization may support increased lean muscle mass and reduced body fat when combined with proper nutrition and exercise.
GH is naturally released during deep sleep. Optimizing GH levels may support more restorative sleep cycles and overall sleep quality.
Often combined with Ipamorelin or other GH secretagogues for enhanced effects—the GHRH analog amplifies what the secretagogue triggers.
GH and IGF-1 decline with age. Restoring more youthful levels may support skin health, energy, cognitive function, and overall vitality.
Your Journey
Our medical team guides you through every step of growth hormone optimization—from initial evaluation to ongoing monitoring.
Meet with our physician to discuss your goals, review health history, and determine if peptide therapy is appropriate for you.
Baseline testing including IGF-1, metabolic panel, and other relevant markers to assess your current hormone status.
Your physician designs a personalized protocol—often combining CJC-1295 with Ipamorelin—tailored to your specific needs and goals.
Regular follow-ups to monitor progress, adjust dosing as needed, and ensure you’re achieving optimal results safely.
Safety & Candidacy
CJC-1295 therapy requires proper medical evaluation and monitoring. Our physicians will assess whether you’re a good candidate based on your health history and goals.
GHRH
Analog that stimulates your body’s own growth hormone production
~30 min
Short half-life preserves natural pulsatile GH release pattern
Questions
CJC-1295 without DAC (also called Mod GRF 1-29) has a short half-life of about 30 minutes, allowing for pulsatile GH release that mimics the body’s natural pattern. CJC-1295 with DAC has a half-life of 6-8 days, causing sustained GH elevation. Most practitioners prefer the “no DAC” version because it’s more physiologic and allows easier dose adjustment.
CJC-1295 stimulates your pituitary gland to produce its own growth hormone, while synthetic HGH (somatropin) introduces external growth hormone directly. The GHRH analog approach is considered more physiologic because it works through your body’s natural feedback systems and preserves pulsatile release patterns.
CJC-1295 (a GHRH analog) and Ipamorelin (a growth hormone secretagogue) work through different mechanisms that complement each other. The GHRH analog amplifies the GH-releasing signal, while the secretagogue triggers the actual release. Together, they can produce greater GH elevation than either alone—this is called synergy.
Due to its short half-life, CJC-1295 no DAC is typically administered 1-3 times daily via subcutaneous injection. Common protocols include dosing before bed (to enhance natural nighttime GH release) or pre-workout. Your physician will design a protocol specific to your goals.
Results vary by individual, but potential benefits include improved recovery from exercise, better sleep quality, positive changes in body composition (more lean mass, less fat), improved skin quality, and enhanced overall vitality. Clinical studies showed 2-10x increases in GH levels and 1.5-3x increases in IGF-1. Results typically develop over weeks to months of consistent use.
Common side effects may include flushing, headache, dizziness, nausea, and injection site reactions. These are typically mild and transient. Because GH can affect blood sugar and other metabolic parameters, proper medical supervision and monitoring are essential.
CJC-1295 is not appropriate for individuals with active cancer or history of certain cancers (GH can promote cell growth), pregnant or nursing women, or those with certain pituitary conditions. A thorough medical evaluation is required before starting therapy. Our physicians will review your complete health history to determine if you’re a candidate.
Get Started
Schedule a consultation with our medical team to learn if CJC-1295 peptide therapy is right for your health and wellness goals.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*CJC-1295 is a research peptide used in clinical settings for growth hormone optimization. The statistics cited (2-10x GH increase, 1.5-3x IGF-1 increase) are from published clinical studies. Individual results vary. CJC-1295 therapy requires physician evaluation, baseline laboratory testing, and ongoing monitoring. It is not appropriate for individuals with active cancer, certain pituitary conditions, or other contraindications. This therapy should only be undertaken under proper medical supervision. Consult with our medical team to determine if you are a candidate.
